June 12 (Reuters) - Cannimed Therapeutics Inc CMED.TO
* Cannimed Therapeutics Inc reports financial results for Q2 2017
* Qtrly revenue increased to $3.7 million from $2.2 million for comparable period in previous fiscal year
* Qtrly loss per share $0.08 Source text for Eikon: ID:nBw2hkswba Further company coverage: CMED.TO